Kathryn Ann Ryan

UK Health Security Agency

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (10)

Luigi Aurisicchio

Chief Executive Officer

ITALY

View details

Daniel Wright

University of Oxford

UNITED KINGDOM

View details

Isobel Joy McFadzean

GP Clinical Lecturer

Cardiff University

UNITED KINGDOM

View details

Fabio Palombo

Chief scientific officer

Neomatrix biotech

ITALY

View details

Alexandra Spencer

Newcastle University

AUSTRALIA

View details

Teresa Lambe

University of Oxford

UNITED KINGDOM

View details

Alice Halliday

University of Bristol

UNITED KINGDOM

View details

Rajeka Lazarus

University of Bristol

UNITED KINGDOM

View details

Heike Cappel-Porter

University of Bristol

UNITED KINGDOM

View details

Raffaele De Francesco

Professore Ordinario di Microbiologia (BIO/19)

Università degli Studi di Torino

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kathryn Ann Ryan

Research Interests

Explore related searches

Contact this professor

Articles (12)

An Optimised Live Attenuated Influenza Vaccine Ferret Efficacy Model Successfully Translates H1N1 Clinical Data

The Omicron Sub-Variant BA.4 Displays a Remarkable Lack of Clinical Signs in a Golden Syrian Hamster Model of SARS-CoV-2 Infection

Infection with Seasonal H1N1 Influenza Results in Comparable Disease Kinetics and Host Immune Responses in Ferrets and Golden Syrian Hamsters

Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant

SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum

DNA-Vaccine-Induced Immune Response Correlates with Lower Viral SARS-CoV-2 Titers in a Ferret Model

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial

ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models

Sequential delivery of LAIV and SARS-CoV-2 in the ferret model can reduce SARS-CoV-2 shedding and does not result in enhanced lung pathology

Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19

Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial

Collaborators (10)

Luigi Aurisicchio

Daniel Wright

Isobel Joy McFadzean

Fabio Palombo

Alexandra Spencer

Teresa Lambe

Alice Halliday

Rajeka Lazarus

Heike Cappel-Porter

Raffaele De Francesco

Make your next move.